|
ADA. VERTIS-CV: SGLT2-I Ertugliflozin Shows HF Benefit Only in CVOT
|
18 juni 2020 |
|
Hur många personer med diabetes har haft Covid-19 i Sverige. NDR och SoS
|
18 juni 2020 |
|
ADA. Metformin, GLP-1 agonists, and SGLT-2 inhibitors in Type 1 Diabetes
|
17 juni 2020 |
|
ADA. The Debate on Metformin and Insulin Use During Pregnancy Continues
|
17 juni 2020 |
|
ADA. New Physical Activity Recommendations for Adults and Children
|
17 juni 2020 |
|
ADA. HbA1c 2011-2017 In Sweden T1DM, A Life-Time Perspective
|
17 juni 2020 |
|
ADA. SILVER study shows sustained benefits with CGM use for MDI users. Marcus Lind
|
17 juni 2020 |
|
ADA. DAPA-HF: Dapagliflozin Slows T2D Onset in Heart Failure T2DM Patients
|
17 juni 2020 |
|
ADA. Automated Insulin Delivery System Getting Better and Better
|
17 juni 2020 |
|
ADA. FreeStyle Libre Glucose Monitor Reduces Hospitalizations in Diabetes
|
17 juni 2020 |
